Using ultra-wideband radar combined with proprietary imaging algorithms, the device delivers real-time visuals even in dense or obstructed environments.

This marks the company’s fourth FDA clearance and brings advanced artificial intelligence tools to hospitals and labs across the United States.

Embryologists traditionally rely on visual assessments to identify suitable sperm cells, but this method is highly subjective and often ineffective.